Adenomyosis as an optional risk factor for uterine cancer

D. F. Kostyuchek , N. M. Anichkov , V. А. Pechenikova

Journal of obstetrics and women's diseases ›› 2004, Vol. 53 ›› Issue (4) : 11 -17.

PDF
Journal of obstetrics and women's diseases ›› 2004, Vol. 53 ›› Issue (4) : 11 -17. DOI: 10.17816/JOWD88606
Current public health problems
research-article

Adenomyosis as an optional risk factor for uterine cancer

Author information +
History +
PDF

Abstract

The problem of adenomyosis malignization is controversial and insufficiently explored. Rate of the malignant transformation of adenomyosis varies from O.l to 24 per cent; as a rule, malignization of the stromal component of adenomyosis is described, works containing cancerous transformation description are isolated ones. Comparative clinical and morphological and immunohistochemical investigation of the cancerous transformation of adenomyosis (6 observations), endometrium cancer in combination with adenomyosis (16 observations), and typical adenomyosis (9 observations) is carried out. Obtained data indicate the precancerous optional significance of adenomyosis, risk of which increases in senior age groups. Endometrial adenocarcinoma does not exhibit a tendency to invasive growth into adenomyosis nidi; combined independent development of endometrium cancer and adenomyosis malignization with exo- and endophyte growth is possible, which determines the hypodiagnostics of malignizated adenomyosis. Morphological verification of malignizated adenomyosis demands comprehensive clinical and morphological investigation with broad study of operating material and with taking into consideration the stages of cancerous transformation morphogenesis established during the work. Late diagnostics and inadequate surgical treatment diagnose the unfavorable prognosis.

Keywords

uterus / adenomyosis / cancerous transformation / morphological diagnosis

Cite this article

Download citation ▾
D. F. Kostyuchek, N. M. Anichkov, V. А. Pechenikova. Adenomyosis as an optional risk factor for uterine cancer. Journal of obstetrics and women's diseases, 2004, 53(4): 11-17 DOI:10.17816/JOWD88606

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Адамян Л.В., Кулаков В.И. Эндометриозы: Руководство для врачей. — М.: Медицина, 1998. — 320 с.

[2]

Аничков Н.М., Кветной И.М., Коновалов С.С. Биология опухолевого роста (молекулярно-медицинские аспекты). - СПб.: Прайм-ЕВРОЗНАК, 2004,- М.: ОЛМА- ПРЕСС, 2004. - 216 с.

[3]

Баскаков В.П., Цвелев Ю.В., Кира Е.Ф. Эндометриоидная болезнь. — СПб.: Изд-во Н-Л, 2002. - 452 с.

[4]

Бохман Я.В., Баскаков В.П., Колосов А.Е.Онкологические аспекты эндометриоза // Акуш. и гин. — 1979. - № 10. - С. 47-49.

[5]

Бохман Я.В. Руководство по онкогинекологии. — СПб.: Фолиант, 2002. - 464 с.

[6]

Дамиров М.М. Аденомиоз: клиника, диагностика и лечение. - Москва-Тверь: Триада, 2002. — 294 с.

[7]

Железнов Б.И., Стрижаков А.Н. Генитальный эндометриоз. — М.: Медицина, 1985. — 189 с.

[8]

Ищенко А.И., Кудрина Е.А. Эндометриоз: диагностика и лечение. - М., 2002.

[9]

Куценко И.И. Генитальный эндометриоз проблемы диагностики и лечения. — Краснодар, 1994. — 189 с.

[10]

Майер И.О., Данелия Г.С. Сочетание эндометриоза и миомы тела матки // Акуш. и гин. — 1983. — № 11. — С. 58-59.

[11]

Пожарисский К.М., Леенман Е.Е. Значение иммуногистохимических методик для определения характера лечения и прогноза опухолевых заболеваний // Арх. патологии. - 2000. - Т. 62, № 5. - С. 3-11.

[12]

Сидорова И.С., Коган Е.А., Зайратьянц О.В. и др. Новый взгляд на природу эндометриоза (аденомиоза) // Акуш. и гин. - 2002. - № 3. - С. 32-38.

[13]

Hernandez E., Woodruff J.D. Endometrial adenocarcinoma arising in adenomyosis // Amer. J. Obstet. Gyn. - 1980. - 138 (7): 827-32.

[14]

Srodon M., Klein W.M., Kurman R.J. CD 10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis // Amer. J. Surg. Path. - 2003. - 27 (6): 786-9.

[15]

Han А.С., Hovenden S., Rosenblum N.G., Salazar Н. Adenocarcinoma arising in extragonadal endometriosis an immunohistochemical study // Cancer. - 1998. - 83 (6): 1163.

RIGHTS & PERMISSIONS

Eсо-Vector

AI Summary AI Mindmap
PDF

109

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/